Vioxx – News, Research and Analysis – The Conversation

Observational scientists study subjects in real life, outside a controlled laboratory environment. from shutterstock.com

March 22, 2016

In defence of observational science: randomised experiments aren’t the only way to the truth

Kathryn Snow, University of Melbourne

The randomised controlled trial is touted as the gold standard in medical research. But its controlled laboratory conditions are far removed from the messy realities of life.

Events disturbingly similar to the thalidomide tragedy continue to occur. funnyangel/Shutterstock

December 9, 2015

Regulations have improved since thalidomide but drug scares are still possible

Wendy Lipworth, University of Sydney

Tighter regulations of medicines and devices have prevented countless deaths and disabilities. But regulation can't always protect us from harm.

Vioxx is the quintessential story of what can go wrong when a big pharmaceutical company exerts influence over the evidence base. AAP

April 3, 2012

Pharma’s influence over published clinical evidence

Adam Dunn, UNSW

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…

Vioxx was withdrawn from the Australian market in October 2004 and there’s an ongoing compensation case. DaGoaty/Flickr

October 20, 2011

Vioxx withdrawal: making sense of the fight for compensation in Australia

Bill Madden, Western Sydney University

The enormous medical impact of modern pharmaceuticals has on occasion been matched by some large-scale litigation regarding adverse events. The Vioxx litigation in Australia and elsewhere is one such recent…

Articles on Vioxx

Displaying all articles